scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Kevin Laupland | Q87139465 |
P2093 | author name string | Johann D D Pitout | |
P2860 | cites work | The changing epidemiology of Staphylococcus aureus? | Q22305657 |
Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 | ||
The CTX-M beta-lactamase pandemic. | Q30356558 | ||
Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region | Q33856392 | ||
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
Molecular detection of antimicrobial resistance | Q33975793 | ||
Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. | Q33976916 | ||
Rapid discriminatory detection of genes coding for SHV beta-lactamases by ligase chain reaction | Q33980007 | ||
Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases | Q33982263 | ||
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
The new beta-lactamases. | Q33984601 | ||
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome | Q34106854 | ||
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). | Q34135508 | ||
Controversies about extended-spectrum and AmpC beta-lactamases | Q34213755 | ||
CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem | Q34973754 | ||
Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes | Q35006613 | ||
Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing | Q35635686 | ||
Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamases | Q35638321 | ||
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases | Q35754705 | ||
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates | Q35758933 | ||
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment | Q35840852 | ||
Genetic methods for detection of antimicrobial resistance | Q36003062 | ||
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community | Q36139832 | ||
Molecular detection of antibiotic resistance: when and where? | Q36169044 | ||
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America | Q36382134 | ||
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. | Q36598540 | ||
CTX-M: changing the face of ESBLs in Europe | Q36678524 | ||
Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond | Q36700241 | ||
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study | Q36880729 | ||
Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp | Q37702466 | ||
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates | Q38475591 | ||
Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR | Q39477822 | ||
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae | Q42167308 | ||
CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece | Q42551507 | ||
bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. | Q42708799 | ||
Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q42912527 | ||
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection | Q43843241 | ||
Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes | Q44142354 | ||
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes | Q44436393 | ||
Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards | Q44580618 | ||
Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period | Q44640091 | ||
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin | Q44709393 | ||
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases | Q44943295 | ||
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes | Q44959090 | ||
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. | Q45044150 | ||
Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. | Q45244902 | ||
A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum beta-lactamases. | Q50700097 | ||
Bacterial resistance: origins, epidemiology, and impact. | Q52282006 | ||
Evolution and clinical importance of extended-spectrum beta-lactamases. | Q54021930 | ||
In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. | Q54354740 | ||
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. | Q54452583 | ||
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli. | Q54457021 | ||
Performance in detection and reporting beta-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories. | Q54465752 | ||
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. | Q54631687 | ||
Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum- -lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate | Q58866123 | ||
Detection of mutations conferring extended-spectrum activity on SHV beta-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP) | Q71299726 | ||
Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia | Q78408808 | ||
Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases | Q79436347 | ||
Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae | Q80055058 | ||
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates | Q80258308 | ||
Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital | Q82703807 | ||
P433 | issue | 3 | |
P921 | main subject | public health | Q189603 |
Enterobacteriaceae | Q380136 | ||
P304 | page(s) | 159-166 | |
P577 | publication date | 2008-03-01 | |
P1433 | published in | Lancet Infectious Diseases | Q15724248 |
P1476 | title | Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | |
P478 | volume | 8 |
Q92635807 | A High Resolution DNA Melting Curve Analysis for the Rapid and Efficient Molecular Diagnostics of Extended Spectrum β-Lactamase Determinants from Foodborne Escherichia coli |
Q37023191 | A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae |
Q94140236 | A Programmable Digital Microfluidic Assay for the Simultaneous Detection of Multiple Anti-Microbial Resistance Genes |
Q40083163 | A Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium |
Q40050797 | A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients. |
Q35086954 | A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota. |
Q40954637 | A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain |
Q21131083 | A new strategy to fight antimicrobial resistance: the revival of old antibiotics |
Q89821618 | A pilot study using environmental screening to determine the prevalence of Mycobacterium avium subspecies paratuberculosis (MAP) and antimicrobial resistance (AMR) in Irish cattle herds |
Q30986331 | A qPCR and multiplex pyrosequencing assay combined with automated data processing for rapid and unambiguous detection of ESBL-producers Enterobacteriaceae |
Q33606193 | A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department users |
Q35607484 | A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing |
Q34398603 | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. |
Q90038693 | A survey of extended-spectrum beta-lactamase-producing Enterobacteriaceae in urban wetlands in southwestern Nigeria as a step towards generating prevalence maps of antimicrobial resistance |
Q40912929 | A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases |
Q35848981 | Activity of Fosfomycin against Extended-Spectrum-β-Lactamase-Producing Uropathogens in Patients in the Community and Hospitalized Patients |
Q34932937 | Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases. |
Q40735145 | Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli |
Q41559832 | Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15. |
Q53731306 | Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens. |
Q46304823 | Age-Related Trends in Adults with Community-Onset Bacteremia |
Q59790104 | Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study |
Q37455103 | Alterations in antibiotic susceptibility of urinary tract infection pathogens. |
Q36933507 | Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae |
Q35805673 | Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae |
Q51035217 | Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. |
Q53552462 | Amperometric detection of extended-spectrum β-lactamase activity: application to the characterization of resistant E. coli strains. |
Q51298402 | An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area. |
Q64978675 | An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. |
Q51275947 | An evolutionarily conserved allosteric site modulates beta-lactamase activity. |
Q42238142 | An outbreak of CTX-M-15 -producing Escherichia coli, Enterobacter cloacae, and Klebsiella in a children's hospital in Finland |
Q38724222 | Analysis of bla(CTX-M)-carrying plasmids from Escherichia coli isolates collected in the BfT-GermVet study |
Q35843272 | Antibacterial Effects and Mode of Action of Selected Essential Oils Components against Escherichia coli and Staphylococcus aureus. |
Q43940593 | Antibacterial activity and synergistic effect between watercress extracts, 2-phenylethyl isothiocyanate and antibiotics against 11 isolates of Escherichia coli from clinical and animal source |
Q49376241 | Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation |
Q90671268 | Antibiotic Resistance Profile and Diversity of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam |
Q35634083 | Antibiotic Resistance in Neonatal Intensive Care Unit Pathogens: Mechanisms, Clinical Impact, and Prevention Including Antibiotic Stewardship |
Q34456773 | Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment |
Q33842030 | Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples. |
Q37291366 | Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications. |
Q39092050 | Antibiotic resistance in wastewater: occurrence and fate of Enterobacteriaceae producers of class A and class C β-lactamases. |
Q34299012 | Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model |
Q35115778 | Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series |
Q94500513 | Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis |
Q36595848 | Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world |
Q51547630 | Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes. |
Q36075871 | Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro. |
Q92505594 | Antimicrobial Resistance Factors of Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae Isolated from Cattle Farms and Raw Beef in North-West Province, South Africa |
Q40323965 | Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases and Other Escherichia coli Isolated from Food of Animal Origin and Human Intestinal Isolates |
Q91829224 | Antimicrobial Resistance and Resistance Determinant Insights into Multi-Drug Resistant Gram-Negative Bacteria Isolates from Paediatric Patients in China |
Q93048432 | Antimicrobial Resistance, Virulence Factors, and Pathotypes of Escherichia coli Isolated from Drinking Water Sources in Jordan |
Q40047461 | Antimicrobial Susceptibility Pattern of Extended-spectrum Beta-lactamases Producing Organisms Isolated in a Tertiary Care Hospital, Bangladesh |
Q36570484 | Antimicrobial drug-resistant Escherichia coli in wild birds and free-range poultry, Bangladesh |
Q47792770 | Antimicrobial resistance among children in sub-Saharan Africa. |
Q37119884 | Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013. |
Q37356539 | Antimicrobial resistance in zoonotic bacteria: lessons learned from host-specific pathogens |
Q33760545 | Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China |
Q30377725 | Antimicrobial resistance profiles and molecular characterization of Escherichia coli strains isolated from healthy adults in Ho Chi Minh City, Vietnam. |
Q64901592 | Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017). |
Q28485932 | Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh |
Q55444694 | Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). |
Q37704754 | Antimicrobial susceptibility of uropathogens isolated from Cambodian children |
Q33834243 | Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital |
Q40622938 | Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment |
Q35135491 | Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. |
Q26739860 | Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). |
Q35408392 | Application of swine manure on agricultural fields contributes to extended-spectrum β-lactamase-producing Escherichia coli spread in Tai'an, China |
Q34426513 | Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance |
Q64258452 | Assessing Molecular Epidemiology of Carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China |
Q37466572 | Assessment of extended-spectrum β-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran. |
Q37120182 | Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014 |
Q99712409 | Assessment of urinary pharmacokinetic and pharmacodynamic profiles of faropenem against extended-spectrum β-lactamase-producing Escherichia coli with canine ex vivo modelling: a pilot study |
Q60309718 | Association between Beta-lactam Antibiotic Resistance and Virulence Factors in AmpC Producing Clinical Strains of |
Q41072200 | Association between Virulence Factors and Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Compared to Nonproducing Isolates. |
Q92792026 | Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study |
Q54341490 | Bacterial sepsis following prostatic biopsy. |
Q40781932 | Bacteriology and antimicrobial susceptibility of ESBLs producers from pus in patients with abdominal trauma associated intra-abdominal infections |
Q37240274 | Bacteriophage tailspike protein based assay to monitor phase variable glucosylations in Salmonella O-antigens |
Q89543255 | Bacterioplankton community variation in Bohai Bay (China) is explained by joint effects of environmental and spatial factors |
Q29616084 | Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America |
Q33673654 | Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome |
Q36870786 | Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy |
Q26795565 | Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria |
Q38694666 | Bloodstream infections in internal medicine. |
Q26765868 | Breaking the Spell: Combating Multidrug Resistant 'Superbugs' |
Q30415141 | CTX-M Enzymes: Origin and Diffusion |
Q42574879 | CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines |
Q34603776 | CTX-M beta-lactamase production and virulence of Escherichia coli K1 |
Q37053548 | CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals. |
Q55154197 | CTX-M-15 is Established in Most Multidrug-Resistant Uropathogenic Enterobacteriaceae and Pseudomonaceae from Hospitals in Nigeria. |
Q46283648 | CTX-M-15-producing Shewanella sp. clinical isolate expressing OXA-535, a chromosome-encoded OXA-48 variant, putative progenitor of the plasmid-encoded OXA-436. |
Q37538628 | CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate. |
Q35134784 | CTX-M-2-producing Salmonella Typhimurium isolated from pediatric patients and poultry in Brazil |
Q54413749 | Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine. |
Q36212092 | Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. |
Q38152302 | Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices |
Q27002495 | Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis |
Q89849315 | Catheter-Related ESBL-Producing Leclercia adecarboxylata Septicemia in Hemodialysis Patient: An Emerging Pathogen? |
Q36973200 | Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012. |
Q36878269 | Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. |
Q45341557 | Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters |
Q33598276 | Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia |
Q36438937 | Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection |
Q33816309 | Cefotaxime-resistant Salmonella enterica in travelers returning from Thailand to Finland |
Q34244192 | Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase. |
Q38740494 | Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections |
Q39037981 | Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections. |
Q48274228 | Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients |
Q54379378 | Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case–control study in a French teaching hospital |
Q92918587 | Change in the Annual Antibiotic Susceptibility of Escherichia coli in Community-Onset Urinary Tract Infection between 2008 and 2017 in a Tertiary Care Hospital in Korea |
Q90115946 | Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli |
Q44678593 | Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread |
Q41773965 | Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria |
Q64106427 | Changing paradigm of antibiotic resistance amongst Escherichia coli isolates in Indian pediatric population |
Q40214475 | Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study. |
Q40410184 | Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand |
Q37025251 | Characteristics and management of Enterobacteriaceae harboring IMP-4 or IMP-8 carbapenemase in a tertiary hospital |
Q33798233 | Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage |
Q36294435 | Characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from fecal samples of piglets with diarrhea in central and southern Taiwan in 2015 |
Q41747974 | Characterization and Antimicrobial Activity of Volatile Constituents from Fresh Fruits of Alchornea cordifolia and Canthium subcordatum |
Q54291041 | Characterization of CTX-M-producing Escherichia coli by repetitive sequence-based PCR and real-time PCR-based replicon typing of CTX-M-15 plasmids. |
Q36708459 | Characterization of Extended-Spectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria |
Q40323915 | Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Pigs and Farm Workers |
Q35747796 | Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan |
Q42654284 | Characterization of Four Multidrug Resistance Plasmids Captured from the Sediments of an Urban Coastal Wetland |
Q35833277 | Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak |
Q40890558 | Characterization of a CTX-M-15 Producing Klebsiella Pneumoniae Outbreak Strain Assigned to a Novel Sequence Type (1427). |
Q46804744 | Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains |
Q40330733 | Characterization of a novel metallo-β-lactamases fold hydrolase from Pelagibacterium halotolerans, a marine halotolerant bacterium isolated from East China Sea. |
Q54307580 | Characterization of antibiotic-resistance genes in antibiotic resistance Escherichia coli isolates from a lake. |
Q54240932 | Characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from Riyadh, Saudi Arabia. |
Q35940783 | Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm |
Q37026386 | Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. |
Q37639669 | Characterization of integrons among Escherichia coli in a region at high incidence of ESBL-EC. |
Q52300037 | Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. |
Q53765869 | Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy. |
Q40131042 | Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital |
Q37705545 | Clinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female Outpatients |
Q26781236 | Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses |
Q35867321 | Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States |
Q38970658 | Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase. |
Q35065929 | Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands |
Q46544388 | Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan |
Q50997686 | Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department. |
Q54315149 | Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea. |
Q90102788 | Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales |
Q37612207 | Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retros |
Q35607768 | Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648 |
Q33566287 | Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae |
Q90182107 | Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli |
Q53684270 | Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study. |
Q46247265 | Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards |
Q33791265 | Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital |
Q44171558 | Clinical significance of infections caused by plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamase-producing Escherichia coli |
Q94545197 | Clinically Relevant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates From Food Animals in South Korea |
Q36505381 | Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries |
Q64912631 | Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings. |
Q35306037 | Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal |
Q41201549 | Co-prevalance of PMQR and 16S rRNA methylase genes in clinical Escherichia coli isolates with high diversity of CTX-M from diseased farmed pigeons |
Q37599342 | Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli |
Q89456253 | Colistin-resistant Escherichia coli carrying mcr-1 in food, water, hand rinse, and healthy human gut in Bangladesh |
Q38185120 | Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective. |
Q41866259 | Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli. |
Q37798897 | Combating evolution with intelligent design: the neoglycoside ACHN-490 |
Q53797688 | Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli. |
Q35559648 | Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal. |
Q42558984 | Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients |
Q35552650 | Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae |
Q92620234 | Comparative Genome-Scale Metabolic Modeling of Metallo-Beta-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates |
Q35005608 | Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, The Netherlands and Germany |
Q43130173 | Comparative analysis of extended-spectrum-{beta}-lactamase-carrying plasmids from different members of Enterobacteriaceae isolated from poultry, pigs and humans: evidence for a shared {beta}-lactam resistance gene pool? |
Q38681779 | Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis |
Q35082753 | Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria |
Q92327785 | Comparison of Four Commercial Screening Assays for the Detection of blaKPC, blaNDM, blaIMP, blaVIM, and blaOXA48 in Rectal Secretion Collected by Swabs |
Q40874147 | Comparison of Three Biochemical Tests for Rapid Detection of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae |
Q41433212 | Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities |
Q41893419 | Comparison of five media for detection of extended-spectrum Beta-lactamase by use of the wasp instrument for automated specimen processing |
Q34995541 | Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli |
Q28474528 | Complete nucleotide sequence of CTX-M-15-plasmids from clinical Escherichia coli isolates: insertional events of transposons and insertion sequences |
Q42047074 | Complete nucleotide sequence of plasmid pTN48, encoding the CTX-M-14 extended-spectrum β-lactamase from an Escherichia coli O102-ST405 strain |
Q35607920 | Complete nucleotide sequences of bla(CTX-M)-harboring IncF plasmids from community-associated Escherichia coli strains in the United States |
Q53704735 | Comprehensive Molecular Characterization of Escherichia coli Isolates from Urine Samples of Hospitalized Patients in Rio de Janeiro, Brazil. |
Q45739887 | Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates |
Q41004466 | Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae |
Q34150900 | Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy |
Q33652427 | Cotrimoxazole - optimal dosing in the critically ill. |
Q40337340 | Cranberry capsules to prevent nosocomial urinary tract bacteriuria after pelvic surgery: a randomised controlled trial. |
Q27670888 | Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance |
Q98159642 | Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis |
Q24612271 | Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa |
Q37720801 | Cyclic Boronates Inhibit All Classes of β-Lactamases |
Q34299058 | Deletion mutations conferring substrate spectrum extension in the class A β-lactamase. |
Q59810354 | Descriptive Epidemiology of Acute Pyelonephritis in Korea, 2010-2014: Population-based Study |
Q51733061 | Designing Superoxide-Generating Quantum Dots for Selective Light-Activated Nanotherapy. |
Q40682992 | Detection and characterization of extended-spectrum β-lactamase-producing Escherichia coli from chicken production chains in Nigeria |
Q36641097 | Detection and characterization of extended-spectrum β-lactamases (blaCTX-M-1 and blaSHV ) producing Escherichia coli, Salmonella spp. and Klebsiella pneumoniae isolated from humans in Mizoram |
Q40095174 | Detection of CTX-M-15 Among Uropathogenic Escherichia coli Isolated from Five Major Hospitals in Tripoli, Libya |
Q42127782 | Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels |
Q41087121 | Detection of Extended-Spectrum β-Lactamase and Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli Isolates from Retail Meat in China |
Q36087090 | Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology |
Q41971522 | Detection of a CTX-M group 2 beta-lactamase gene in a Klebsiella pneumoniae isolate from a tertiary care hospital, Trinidad and Tobago |
Q42280677 | Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium |
Q42933170 | Detection of extended-spectrum β-lactamases in Klebsiella pneumoniae: comparison of phenotypic characterization methods. |
Q37546694 | Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains. |
Q42258248 | Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group. |
Q33901083 | Development and validation of a resistance and virulence gene microarray targeting Escherichia coli and Salmonella enterica |
Q53083132 | Development of a Luminex xTAG® assay for cost-effective multiplex detection of β-lactamases in Gram-negative bacteria. |
Q90151752 | Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae |
Q41143762 | Development of a multiplex PCR system and its application in detection of blaSHV, blaTEM, blaCTX-M-1, blaCTX-M-9 and blaOXA-1 group genes in clinical Klebsiella pneumoniae and Escherichia coli strains |
Q33916223 | Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae |
Q61818375 | Diarrheal bacterial pathogens and multi-resistant enterobacteria in the Choqueyapu River in La Paz, Bolivia |
Q34198942 | Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study |
Q33466737 | Differential regulation of horizontally acquired and core genome genes by the bacterial modulator H-NS. |
Q34402917 | Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis |
Q40517201 | Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resista |
Q36969909 | Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trend |
Q89449909 | Diversity among blaKPC-containing plasmids in Escherichia coli and other bacterial species isolated from the same patients |
Q30389929 | Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study |
Q54340237 | Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission. |
Q92970844 | Diversity, Virulence, and Clinical Significance of Extended-Spectrum β-Lactamase- and pAmpC-Producing Escherichia coli From Companion Animals |
Q60053842 | Duration of Colonization by Extended-Spectrum β-Lactamase-Producing in Healthy Newborns and Associated Risk Factors: A Prospective Cohort Study |
Q40219287 | ESBL carriage in pig slaughterhouse workers is associated with occupational exposure. |
Q61818384 | ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes |
Q35101453 | ESBLs: A Clear and Present Danger? |
Q37544901 | Early-onset neonatal sepsis. |
Q57055898 | Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial |
Q61727885 | Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial |
Q33534910 | Effect of ethnomedicinal plants used in folklore medicine in Jordan as antibiotic resistant inhibitors on Escherichia coli |
Q34701924 | Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae |
Q90071190 | Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis |
Q35867313 | Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. |
Q41786410 | Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers |
Q60300553 | Emergence and molecular characterization of multidrug-resistant isolates harboring extended-spectrum β-lactamases causing ventilator-associated pneumonia in China |
Q59336637 | Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study |
Q36667172 | Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients |
Q42331477 | Emerging Perils of Extended Spectrum β-Lactamase Producing Enterobacteriaceae Clinical Isolates in a Teaching Hospital of Nepal |
Q38088261 | Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections |
Q35539847 | Emissions of Escherichia coli carrying extended-spectrum β-lactamase resistance from pig farms to the surrounding environment |
Q41987129 | Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort |
Q21146707 | Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options |
Q38749799 | Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches. |
Q48670663 | Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next? |
Q43117801 | Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units |
Q38029012 | Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance |
Q49977272 | Environmental adaptation and vertical dissemination of ESBL-/pAmpC-producing Escherichia coli in an integrated broiler production chain in the absence of an antibiotic treatment. |
Q34575092 | Epidemic plasmid carrying bla(CTX-M-15) in Klebsiella penumoniae in China |
Q35811323 | Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond |
Q35644344 | Epidemiology and characteristics of urinary tract infections in children and adolescents. |
Q41195981 | Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies |
Q37036459 | Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center. |
Q35689050 | Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains |
Q36305006 | Epidemiology of Carbapenem Resistance among Multi-drug Resistant Enterobacteriaceae in Uganda |
Q39638797 | Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan |
Q64101197 | Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia |
Q36901488 | Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study |
Q39956534 | Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes |
Q34100039 | Ertapenem-induced reduction in valproate levels: case report and review of the literature |
Q40312323 | Erythromycin oxidation and ERY-resistant Escherichia coli inactivation in urban wastewater by sulfate radical-based oxidation process under UV-C irradiation. |
Q64962551 | Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics. |
Q39201659 | Escherichia coli ST131: a multidrug-resistant clone primed for global domination. |
Q43230989 | Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy |
Q37220795 | Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans |
Q33963663 | Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates |
Q50095632 | Evaluation of the β-Lacta Test for Detection of Extended-Spectrum-β-Lactamase (ESBL)-Producing Organisms Directly from Positive Blood Cultures by Use of Smudge Plates |
Q42872010 | Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae. |
Q47595845 | Evolution of conformational dynamics determines the conversion of a promiscuous generalist into a specialist enzyme. |
Q28472615 | Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance |
Q89939403 | Experience With Ceftolozane-Tazobactam for the Treatment of Serious Pseudomonas aeruginosa Infections in Saudi Tertiary Care Center |
Q33893632 | Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems |
Q37564145 | Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli in meat in Denmark |
Q82796919 | Expression of ESBL-like activity in infrequently encountered members of the family Enterobacteriaceae |
Q51833801 | Extended spectrum beta-lactamase carriage state among elderly nursing home residents in Beirut. |
Q39233531 | Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern |
Q92054933 | Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal |
Q47965283 | Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome. |
Q35630038 | Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution? |
Q36192755 | Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia |
Q94593498 | Extended-Spectrum β-Lactamase (ESBL) Genotypes among Multidrug-Resistant Uropathogenic Escherichia coli Clinical Isolates from a Teaching Hospital of Nepal |
Q99634804 | Extended-Spectrum β-Lactamase-Producing Enterobacterales Shedding by Dogs and Cats Hospitalized in an Emergency and Critical Care Department of a Veterinary Teaching Hospital |
Q37512490 | Extended-Spectrum-Beta-Lactamase- and Plasmid-Encoded Cephamycinase-Producing Enterobacteria in the Broiler Hatchery as a Potential Mode of Pseudo-Vertical Transmission. |
Q34738249 | Extended-spectrum Beta-lactamase gene sequences in gram-negative saprophytes on retail organic and nonorganic spinach |
Q64247726 | Extended-spectrum beta-lactamase production and multi-drug resistance among isolated in Addis Ababa, Ethiopia |
Q35097441 | Extended-spectrum beta-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings |
Q34079113 | Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae |
Q45994003 | Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07. |
Q40004163 | Extended-spectrum β-lactamase CTX-M-15-producing Klebsiella pneumoniae of sequence type ST274 in companion animals |
Q90431209 | Extended-spectrum β-lactamase prevalence and virulence factor characterization of enterotoxigenic Escherichia coli responsible for acute diarrhea in Nepal from 2001 to 2016 |
Q38191750 | Extended-spectrum β-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals. |
Q58798150 | Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins |
Q35555196 | Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat |
Q54333977 | Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline. |
Q54355249 | Extended-spectrum β-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients. |
Q51445786 | Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. |
Q37322827 | Extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in São Luís, Brazil |
Q39256669 | Extensive dissemination of CTX-M-1- and CMY-2-producing Escherichia coli in poultry farms in Tunisia |
Q35681590 | Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance |
Q38063968 | Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment |
Q54249766 | Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. |
Q39409432 | Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and Shiga toxin-producing Escherichia coli in asymptomatic nursery children in Lower Saxony (Germany), 2014. |
Q54972417 | Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students. |
Q64955622 | Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase. |
Q30433281 | Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients |
Q48165659 | Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study. |
Q38824989 | Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis |
Q64084699 | Fecal Colonization With Multidrug-Resistant Among Healthy Infants in Rural Bangladesh |
Q34532665 | Fecal carriage of ESBL-producing E. coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based cross-sectional study |
Q38461358 | Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings |
Q38893310 | Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca. |
Q33936856 | Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community |
Q45950234 | Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime. |
Q33909472 | First description of an extended-spectrum-beta-lactamase-producing multidrug-resistant Escherichia fergusonii strain in a patient with cystitis. |
Q33455526 | Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle |
Q94547205 | Fluorescent Materials With Aggregation-Induced Emission Characteristics for Array-Based Sensing Assay |
Q42326525 | Fluoroquinolone resistance among gram-negative urinary tract pathogens: global smart program results, 2009-2010 |
Q38848662 | Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage |
Q36948797 | Food and human gut as reservoirs of transferable antibiotic resistance encoding genes |
Q34096605 | Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. |
Q43662701 | Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria |
Q37224528 | Frequency and characteristics of infections caused by extended-spectrum beta-lactamase-producing organisms in neonates: a prospective cohort study |
Q90447899 | Frequency and molecular epidemiology of class A ESBLs producing Enteroinvasive Escherichia coli (EIEC) isolates among patients with diarrhea |
Q36757319 | Frequent occurrence of extended-spectrum beta-lactamase- and transferable ampc beta-lactamase-producing Escherichia coli on domestic chicken meat in Sweden. |
Q35744395 | Functional metagenomics reveals previously unrecognized diversity of antibiotic resistance genes in gulls |
Q43128332 | Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa |
Q53745020 | Genetic Background of β-Lactamases in Enterobacteriaceae Isolates from Environmental Samples. |
Q28547890 | Genetic Environment of Plasmid Mediated CTX-M-15 Extended Spectrum Beta-Lactamases from Clinical and Food Borne Bacteria in North-Eastern India |
Q45035824 | Genetic and phenotypic characterisation of Escherichia coli producing cefotaximase-type extended-spectrum β-lactamases: first evidence of the ST131 clone in cats with urinary infections in Italy |
Q28112087 | Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene |
Q30836432 | Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data |
Q36337074 | Global fluoroquinolone resistance epidemiology and implictions for clinical use. |
Q35847641 | Global spread of Carbapenemase-producing Enterobacteriaceae |
Q36525333 | Globally dispersed mobile drug-resistance genes in gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital |
Q43237187 | Gram-negative bloodstream infections |
Q55091640 | Guidelines for the treatment of severe acute malnutrition: a systematic review of the evidence for antimicrobial therapy. |
Q51347384 | Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms. |
Q35869239 | High Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands |
Q92809775 | High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba |
Q47194286 | High Prevalence of CTX-M-15-Type ESBL-Producing E. coli from Migratory Avian Species in Pakistan |
Q39414358 | High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics. |
Q34671432 | High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors |
Q33635196 | High diversity of extended-spectrum beta-lactamase-producing bacteria in an urban river sediment habitat |
Q54324569 | High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden. |
Q64086207 | High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals |
Q92416820 | High prevalence and diversity of extended-spectrum β-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia |
Q35222739 | High prevalence and risk factors of fecal carriage of CTX-M type extended-spectrum beta-lactamase-producing Enterobacteriaceae from healthy rural residents of Taian, China |
Q40541461 | High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China |
Q42111425 | High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada |
Q34237433 | High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam |
Q33630862 | High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar |
Q34133230 | High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal |
Q38325523 | High rate of fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain. |
Q42207537 | High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea |
Q43419221 | Highly resistant microorganisms in a teaching hospital: the role of horizontal spread in a setting of endemicity |
Q89537696 | How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections |
Q93085303 | Identification of FosA8, a Plasmid-Encoded Fosfomycin Resistance Determinant from Escherichia coli, and Its Origin in Leclercia adecarboxylata |
Q28546573 | Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae |
Q35065875 | Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system |
Q39613973 | Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections |
Q37974746 | Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption |
Q31102336 | Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study |
Q31151607 | Impact of national policies on the microbial aetiology of surgical site infections in acute NHS hospitals in England: analysis of trends between 2000 and 2013 using multi-centre prospective cohort data |
Q41440864 | Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli. |
Q42141880 | In Vitro Activities of Ertapenem and Imipenem against Clinical Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae Collected in Military Teaching Hospital Mohammed V of Rabat |
Q42844410 | In Vitro Activity of Available Antimicrobial Coated Foley Catheters Against Escherichia coli, Including Strains Resistant to Extended Spectrum Cephalosporins |
Q58730452 | In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait |
Q36571892 | In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains |
Q91803627 | In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model |
Q37389468 | In vitro Effectiveness of Commercial Bacteriophage Cocktails on Diverse Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains |
Q84464779 | In vitro activity of plant extracts and alkaloids against clinical isolates of extended-spectrum β-lactamase (ESBL)-producing strains |
Q40299737 | In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli. |
Q38626867 | In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? |
Q35666617 | In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms |
Q35166517 | IncA/C plasmid-mediated spread of CMY-2 in multidrug-resistant Escherichia coli from food animals in China |
Q40656286 | Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study |
Q46877738 | Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12. |
Q42426450 | Increased frequency of integrons and β-lactamase-coding genes among extraintestinal Escherichia coli isolated with a 7-year interval |
Q37270671 | Increased prevalence of antibiotic-resistant E. coli in gulls sampled in Southcentral Alaska is associated with urban environments |
Q37623473 | Increased waterborne blaNDM-1 resistance gene abundances associated with seasonal human pilgrimages to the upper ganges river |
Q92538005 | Increasing Prevalence of ESBL-Producing Multidrug Resistance Escherichia coli From Diseased Pets in Beijing, China From 2012 to 2017 |
Q46976114 | Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis |
Q42277205 | Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. |
Q97552957 | Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016 |
Q63433699 | Infecciones por enterobacterias |
Q46256441 | Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment |
Q37694529 | Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices |
Q36390405 | Inhibitory Effect of Biosynthesized Silver Nanoparticles from Extract of Nitzschia palea Against Curli-Mediated Biofilm of Escherichia coli. |
Q31148049 | Integration of Biomass Formulations of Genome-Scale Metabolic Models with Experimental Data Reveals Universally Essential Cofactors in Prokaryotes |
Q45994580 | Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children. |
Q35825390 | Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature |
Q39304670 | Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin |
Q44770831 | Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children |
Q36138993 | KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units |
Q40833352 | Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London |
Q37409854 | Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation. |
Q36150730 | Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy |
Q36165510 | Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study |
Q36051105 | Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis. |
Q36667273 | Long-Term Colonization by bla(CTX-M)-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling |
Q34763062 | Longitudinal monitoring of extended-spectrum-beta-lactamase/AmpC-producing Escherichia coli at German broiler chicken fattening farms |
Q41715581 | Loop-mediated isothermal amplification assay targeting the blaCTX-M9 gene for detection of extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae |
Q40663198 | Low Occurrence of Extended-Spectrum β-lactamase-Producing Escherichia coli in Finnish Food-Producing Animals. |
Q38087195 | Management of chemotherapy-induced neutropenic fever |
Q54353726 | Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. |
Q35030247 | Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. |
Q34284603 | Mini-review: Epidemiology and zoonotic potential of multiresistant bacteria and Clostridium difficile in livestock and food |
Q37809057 | Minor extended-spectrum β-lactamases. |
Q35203279 | Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon |
Q38857234 | Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases |
Q64236542 | Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing from a Tertiary Care Hospital |
Q92547760 | Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States |
Q47128982 | Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Escherichia coli Pathotypes in Diarrheal Children from Low Socioeconomic Status Communities in Bihar, India: Emergence of the CTX-M Type |
Q33797958 | Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan |
Q28728384 | Molecular characteristics of extended-spectrum beta-lactamases and qnr determinants in Enterobacter species from Japan |
Q37504205 | Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. |
Q30430793 | Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital |
Q37247785 | Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections |
Q37204201 | Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region |
Q89747930 | Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt |
Q56517171 | Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population |
Q34675362 | Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar |
Q24633808 | Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid |
Q89704623 | Molecular diversity and profile analysis of virulence-associated genes in some Klebsiella pneumoniae isolates |
Q24628782 | Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae |
Q58696360 | Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan |
Q34315040 | Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. |
Q35689028 | Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region |
Q41456628 | Molecular typing of uropathogenic Escherichia coli isolated from Korean children with urinary tract infection. |
Q64105106 | Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017) |
Q40232475 | Mortality Due to Nosocomial Infection with Klebsiella pneumoniae ESBL(). |
Q64135930 | Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection |
Q55479343 | Multi-Drug Resistant Coliform: Water Sanitary Standards and Health Hazards. |
Q91829300 | Multi-Drug Resistant Escherichia coli Causing Early-Onset Neonatal Sepsis - a Single Center Experience from China |
Q40342728 | Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States |
Q35960721 | Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia |
Q36792780 | Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India |
Q39031812 | Multidrug resistant Enterobacteriaceae in New Zealand: a current perspective. |
Q39710822 | Multidrug-resistant Enterobacteriaceae from indoor air of an urban wastewater treatment plant. |
Q42366911 | Multiple Antibiotic-Resistant, Extended Spectrum-β-Lactamase (ESBL)-Producing Enterobacteria in Fresh Seafood |
Q54193787 | Multiplex real-time PCR probe-based for identification of strains producing: OXA48, VIM, KPC and NDM. |
Q37291349 | Multiresistant Enterobacteriaceae: new threat of an old problem |
Q41182987 | Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage |
Q47312911 | Mutual influence of secondary and key drug‐resistance mutations on catalytic properties and thermal stability of TEM‐type β‐lactamases |
Q34309458 | National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases |
Q39991540 | Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting |
Q37767653 | New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance |
Q34212596 | Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study. |
Q37246801 | Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals |
Q54321125 | Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. |
Q35815939 | Occurrence of CTX-M Producing Escherichia coli in Soils, Cattle, and Farm Environment in France (Burgundy Region). |
Q48004158 | Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater. |
Q35852382 | Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany |
Q35667775 | Occurrence of SHV, TEM and CTX-M β-Lactamase Genes Among Enteropathogenic Escherichia coli Strains Isolated From Children With Diarrhea. |
Q42672109 | Occurrence of Salmonella enterica and Escherichia coli in raw chicken and beef meat in northern Egypt and dissemination of their antibiotic resistance markers. |
Q39135840 | Occurrence of bla CTX-M-1, qnrB1 and virulence genes in avian ESBL-producing Escherichia coli isolates from Tunisia |
Q47595207 | Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children |
Q59128524 | One-Dimensional TiO2-B Crystals Synthesised by Hydrothermal Process and Their Antibacterial Behaviour onEscherichia coli |
Q38672016 | Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance |
Q35132012 | Oral amoxicillin-clavulanic Acid treatment in urinary tract infections caused by extended-spectrum Beta-lactamase-producing organisms |
Q37115833 | Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases |
Q40598375 | Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks |
Q34298437 | Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions |
Q35533202 | Pathogenic and commensal Escherichia coli from irrigation water show potential in transmission of extended spectrum and AmpC β-lactamases determinants to isolates from lettuce |
Q53080242 | Pathogenic multiple antimicrobial resistant Escherichia coli serotypes in recreational waters of Mumbai, India: a potential public health risk. |
Q31047716 | Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study |
Q35571382 | Persistence of a pKPN3-like CTX-M-15-encoding IncFIIK plasmid in a Klebsiella pneumonia ST17 host during two years of intestinal colonization |
Q35960788 | Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance |
Q37773368 | Pharmacokinetic evaluation of piperacillin-tazobactam |
Q41917438 | Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli |
Q36055979 | Phenotypic and Molecular Characterisation of Extended-Spectrum Beta-Lactamase Producing Escherichia coli Obtained from Animal Fecal Samples in Ado Ekiti, Nigeria |
Q42379269 | Phenotypic and genotypic characteristics of ESBL and AmpC producing organisms associated with bacteraemia in Ho Chi Minh City, Vietnam |
Q37160150 | Phenotypical characterization and adhesin identification in Escherichia coli strains isolated from dogs with urinary tract infections |
Q35926207 | Photodynamic inactivation of Klebsiella pneumoniae biofilms and planktonic cells by 5-aminolevulinic acid and 5-aminolevulinic acid methyl ester |
Q30354365 | Phylogenetic Analysis of Enteroaggregative Escherichia coli (EAEC) Isolates from Japan Reveals Emergence of CTX-M-14-Producing EAEC O25:H4 Clones Related to Sequence Type 131 |
Q92237043 | Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study |
Q101226482 | Plasmid- and strain-specific factors drive variation in ESBL-plasmid spread in vitro and in vivo |
Q94563655 | Plasmid-mediated antibiotic resistance among uropathogens in primigravid women-Hyderabad, India |
Q37970757 | Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy |
Q34108740 | Plasmid-mediated resistance to cephalosporins in Salmonella enterica serovar Typhi |
Q36926956 | Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing |
Q30402058 | Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307. |
Q90645341 | Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body Sizes |
Q27013639 | Population-based epidemiology and microbiology of community-onset bloodstream infections |
Q40082536 | Preliminary insights into the occurrence of similar clones of extended-spectrum beta-lactamase-producing bacteria in humans, animals and the environment in Tanzania: A systematic review and meta-analysis between 2005 and 2016. |
Q35979859 | Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France |
Q47142542 | Prevalence and Antibiotic Resistance of Non-typhoidal Salmonella Isolated from Raw Chicken Carcasses of Commercial Broilers and Spent Hens in Tai'an, China |
Q39814783 | Prevalence and Risk Factors associated with Extended Spectrum Beta Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolates in Hospitalized Patients in Kashan (Iran). |
Q55365818 | Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia. |
Q36517575 | Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors |
Q91660294 | Prevalence and distribution of blaCTX-M, blaSHV, blaTEM genes in extended- spectrum β- lactamase- producing E. coli isolates from broiler farms in the Philippines |
Q30401450 | Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs |
Q36684170 | Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam |
Q37334691 | Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia |
Q39375018 | Prevalence and spread of multidrug-resistant Escherichia coli including ST131 in different patient populations in the Euroregion Meuse-Rhine |
Q36857383 | Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital |
Q34129686 | Prevalence of antibiotic resistant bacteria in healthy adults, foods, food animals, and the environment in selected areas in Thailand |
Q42374450 | Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark |
Q91576167 | Prevalence of extended-spectrum and AmpC β-lactamase-producing Escherichia coli in Dutch dairy herds |
Q42978682 | Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden |
Q51049695 | Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. |
Q54342147 | Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan. |
Q55368723 | Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations. |
Q41062335 | Prevalence of β-Lactamase Producing Escherichia coli from Retail Meat in Turkey |
Q35738292 | Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology |
Q50878488 | Prevention, removal and inactivation of Escherichia coli and Staphylococcus aureus biofilms using selected monoterpenes of essential oils. |
Q42688454 | Prolonged febrile illness due to CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection in Nigeria |
Q43482683 | Prolonged fecal shedding of CTX-M-15-producing Escherichia coli and recurrent sepsis in a patient after cord blood stem-cell transplantation |
Q43759722 | Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospita |
Q91865096 | Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae |
Q38780024 | Public health risk of antimicrobial resistance transfer from companion animals. |
Q38067695 | Public health risks of enterobacterial isolates producing extended-spectrum β-lactamases or AmpC β-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. |
Q36742408 | Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain |
Q28732678 | RNA-seq based transcriptional map of bovine respiratory disease pathogen "Histophilus somni 2336" |
Q30402760 | Rapid Identification of Different Escherichia coli Sequence Type 131 Clades |
Q46298651 | Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing |
Q35130334 | Rapid detection of ESBL-producing Enterobacteriaceae in blood cultures |
Q42281130 | Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae |
Q34030592 | Rapid detection of urinary tract pathogens using microcalorimetry: principle, technique and first results. |
Q40505708 | Rapid determination of β-lactam antimicrobial resistance in bacteria by a liquid chromatography-mass spectrometry-based method |
Q27666903 | Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex |
Q91754083 | Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae |
Q40014484 | Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae |
Q33987808 | Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar |
Q38280071 | Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study |
Q37124242 | Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women. |
Q41145977 | Renal Abscess Due to Community-acquired Extended-spectrum β-Lactamase-producing Escherichia coli in a 15-Year-old Girl |
Q51545120 | Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. |
Q92579541 | Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015 |
Q63647666 | Resistance mechanisms and population structure of highly drug resistant Klebsiella in Pakistan during the introduction of the carbapenemase NDM-1 |
Q37998398 | Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example |
Q37290720 | Resistant gram-negative infections in the outpatient setting in Latin America |
Q39383695 | Rethinking the composition of a rational antibiotic arsenal for the 21st century |
Q64230326 | Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis |
Q41948199 | Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia. |
Q37559129 | Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections |
Q92997895 | Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016 |
Q33827095 | Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli |
Q54331987 | Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. |
Q36316418 | Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials |
Q34920553 | Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country |
Q36797179 | Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli infection in hospitalized patients |
Q37203077 | Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden |
Q90236140 | Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy |
Q54376284 | Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. |
Q51784460 | Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. |
Q41750938 | Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia |
Q58770648 | Routine detection of carbapenem-resistant gram-negative bacilli in clinical laboratories. A review of current challenge |
Q47150482 | Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals |
Q44691321 | Seasonal and ascending trends in the incidence of carriage of extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella species in 2 German hospitals |
Q89815195 | Seasonality in carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in the general population: a pooled analysis of nationwide cross-sectional studies |
Q50097358 | Selection of ESBL-Producing E. coli in a Mouse Intestinal Colonization Model. |
Q64118965 | Shared Multidrug Resistance Patterns in Chicken-Associated Identified by Association Rule Mining |
Q40208472 | Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study. |
Q54288940 | Sites of colonization with extended-spectrum β-lactamases (ESBL)-producing enterobacteriaceae: the rationale for screening. |
Q60920536 | Spontaneous bacterial peritonitis - therapeutic challenges in the era of increasing drug resistance of bacteria |
Q41002269 | Spread of extended-spectrum beta-lactamase-producing Escherichia coli from a swine farm to the receiving river |
Q24607946 | Strategies to minimize antibiotic resistance |
Q59377088 | Stratégies thérapeutiques dans les infections urinaires du nourrisson et de l’enfant |
Q28547363 | Studies of Antibiotic Resistance of Beta-Lactamase Bacteria under Different Nutrition Limitations at the Single-Cell Level |
Q49961843 | Study of pandrug and heavy metal resistance among E. coli from anthropogenically influenced Delhi stretch of river Yamuna |
Q88801780 | Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization |
Q39878469 | Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae |
Q37912231 | Surveillance and management of multidrug-resistant microorganisms |
Q43118114 | Survey for beta-lactamase among bacterial isolates from Guangzhou, China hospitals between 2005-2006. |
Q42259493 | Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases |
Q41272045 | Susceptibilities of common bacterial isolates from oman to old and new antibiotics |
Q90012985 | Susceptibility of Klebsiella Pneumoniae Isolated from Pus Specimens of Post-Surgery Patients in Medan, Indonesia to Selected Antibiotics |
Q41087404 | Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug-Resistant Enterobacteriaceae |
Q30235041 | Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae |
Q38833839 | Tackling antimicrobial resistance in lower urinary tract infections: treatment options |
Q57174160 | Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein |
Q35131933 | Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study |
Q47151937 | Technical specifications on harmonised epidemiological indicators for biological hazards to be covered by meat inspection of poultry |
Q36061308 | Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe |
Q35572742 | Ten-year surveillance of nosocomial bloodstream infections: trends of aetiology and antimicrobial resistance in a comprehensive cancer centre |
Q38918357 | Tetracycline resistance in semi-arid agricultural soils under long-term swine effluent application |
Q40439056 | Tetramethylbenzidine method for monitoring the free available chlorine and microbicidal activity of chlorite-based sanitizers under organic-matter-rich environments |
Q42777524 | The CTX-M-14 plasmid pHK01 encodes novel small RNAs and influences host growth and motility. |
Q34431394 | The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities |
Q37725893 | The Efficacy of Isolated Bacteriophages from Pig Farms against ESBL/AmpC-Producing Escherichia coli from Pig and Turkey Farms |
Q30855831 | The Lung is a Host Defense Niche for Immediate Neutrophil-Mediated Vascular Protection. |
Q30386217 | The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts. |
Q89761156 | The Prevalence and Characterization of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Bacteria from Hospital Sewage, Treated Effluents and Receiving Rivers |
Q40672387 | The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations. |
Q47427370 | The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections |
Q94948537 | The Role of European Starlings (Sturnus vulgaris) in the Dissemination of Multidrug-Resistant Escherichia coli among Concentrated Animal Feeding Operations |
Q58540591 | The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms |
Q35120750 | The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide |
Q91843293 | The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017 |
Q30375493 | The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation. |
Q38497797 | The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae |
Q37815628 | The continuing crisis in antibiotic resistance |
Q46108324 | The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. |
Q40706134 | The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013. |
Q33686940 | The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies |
Q90101011 | The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone |
Q43509580 | The impact of a single ward for cohorting patients with infection due to multidrug-resistant organisms |
Q42232753 | The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings |
Q90548170 | The impact of nephrostomy drainage prior to mini-percutaneous nephrolithotomy in patients with ESBL-positive Escherichia coli |
Q42219507 | The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). |
Q37569749 | The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia |
Q36651658 | The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home: a cross-sectional comparison |
Q35507460 | The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China |
Q38766625 | The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC. |
Q34969565 | The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria |
Q30300020 | The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae |
Q38017141 | The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae |
Q28474307 | The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam |
Q34214749 | The tandem repeats enabling reversible switching between the two phases of β-lactamase substrate spectrum |
Q37549390 | The tide of antimicrobial resistance and selection |
Q34298172 | The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. |
Q42433179 | Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern |
Q24646623 | Three decades of beta-lactamase inhibitors |
Q37899640 | Tigecycline treatment for urinary tract infections: case report and literature review |
Q53672275 | Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia. |
Q40900561 | Total Synthesis and Structural Reassignment of Aspergillomarasmine A. |
Q33790123 | Transcriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective Antibiotics |
Q52695014 | Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. |
Q95793245 | Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria |
Q38246118 | Treatment option for sepsis in children in the era of antibiotic resistance |
Q38739545 | Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria |
Q39310965 | Treatment strategy for a multidrug-resistant Klebsiella UTI. |
Q33826293 | Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients |
Q49582929 | Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013-2016) study from Aseer region, Saudi Arabia |
Q56909843 | Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010 |
Q92908957 | Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis |
Q34282016 | Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution |
Q98906710 | Twentieth-century emergence of antimicrobial resistant human- and bovine-associated Salmonella enterica serotype Typhimurium lineages in New York State |
Q55114432 | Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults. |
Q47150305 | Urgent advice on the public health risk of Shiga-toxin producingEscherichia coliin fresh vegetables |
Q37766972 | Urinary tract infection in children: when to worry |
Q41900712 | Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. |
Q40044307 | Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae |
Q36668671 | Validation of Cefazolin as Initial Antibiotic for First Upper Urinary Tract Infection in Children |
Q43565864 | Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units |
Q92821474 | Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis |
Q36292839 | Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali |
Q53691748 | Virulence determinant and extended spectrum beta-lactamase production in Klebsiella pneumoniae isolated from a tertiary care hospital, South India. |
Q42931230 | When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France |
Q97067535 | Whole Genome Sequencing and Characterization of Multidrug-Resistant (MDR) Bacterial Strains Isolated From a Norwegian University Campus Pond |
Q40064103 | Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand |
Q91899356 | Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria |
Q58753607 | Whole-Genome Sequence Analysis of CTX-M Containing Escherichia coli Isolates from Retail Meats and Cattle in the United States |
Q41115946 | Whole-Genome Sequences of Multidrug-Resistant Escherichia coli Strains Sharing the Same Sequence Type (ST410) and Isolated from Human and Avian Sources in Italy |
Q64236885 | Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes |
Q84370144 | Wide dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in acute care and rehabilitation hospitals |
Q37544721 | Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States |
Q40337526 | Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies |
Q94475209 | [Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: changes in treatment modalities related to the COVID-19 health crisis] |
Q84127351 | [Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice] |
Q38643867 | p1220-CTXM, a pKP048-related IncFIIK plasmid carrying bla CTX-M-14 and qnrB4. |
Q38076453 | β-Lactam antimicrobials: what have you done for me lately? |
Q50523195 | β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. |
Q36644786 | β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates |
Q38365280 | β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? |
Q38264182 | β-lactam/β-lactamase inhibitor combinations: from then to now. |
Q51048295 | β-lactamase producing enterobacteria isolated from surveillance swabs of patients in a cardiac intensive care unit in Rio de Janeiro, Brazil. |
Search more.